These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27864451)

  • 1. Reacquisition of E-cadherin expression in metastatic deposits of signet-ring cell carcinoma of the upper gastrointestinal system: a potential anchor for metastatic deposition.
    Ma YR; Siegal GP; Wei S
    J Clin Pathol; 2017 Jun; 70(6):528-532. PubMed ID: 27864451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Characteristics and Prognostic Effect of E-Cadherin Expression in Colorectal Signet Ring Cell Carcinoma.
    Wang R; Ma X; Li Y; He Y; Huang D; Cai S; Peng J
    PLoS One; 2016; 11(8):e0160527. PubMed ID: 27509205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct expression patterns of E-cadherin and beta-catenin in signet ring cell carcinoma components of primary pulmonary adenocarcinoma.
    Moon KC; Cho SY; Lee HS; Jeon YK; Chung JH; Jung KC; Chung DH
    Arch Pathol Lab Med; 2006 Sep; 130(9):1320-5. PubMed ID: 16948518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced E-cadherin expression as a cause of distinctive signet-ring cell variant in colorectal carcinoma.
    Kim HC; Kim HJ; Kim JC
    J Korean Med Sci; 2002 Feb; 17(1):23-8. PubMed ID: 11850584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal signet ring cell carcinoma: Influence of EGFR, E-cadherin and MMP-13 expression on clinicopathological features and prognosis.
    Foda AAM; Aziz AA; Mohamed MA
    Ann Diagn Pathol; 2018 Feb; 32():41-46. PubMed ID: 29414397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced E-Cadherin and Aberrant β-Catenin Expression are Associated With Advanced Disease in Signet-Ring Cell Carcinomas.
    Ma YR; Ren Z; Conner MG; Siegal GP; Wei S
    Appl Immunohistochem Mol Morphol; 2017 Jul; 25(6):432-438. PubMed ID: 26808130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differing expression of metalloprotease and of adhesion molecules in signet-ring cell and intestinal colorectal carcinoma.
    Cabibi D; Calascibetta A; Aragona F; Martorana A; Campione M; Sanguedolce R
    Anticancer Res; 2009 Nov; 29(11):4417-22. PubMed ID: 20032387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.
    Jeschke U; Mylonas I; Kuhn C; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2007; 27(4A):1969-74. PubMed ID: 17649807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDH1 gene mutation in early-onset, colorectal signet-ring cell carcinoma.
    Aitchison A; Hakkaart C; Whitehead M; Khan S; Siddique S; Ahmed R; Frizelle FA; Keenan JI
    Pathol Res Pract; 2020 May; 216(5):152912. PubMed ID: 32147272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signet ring cell carcinoma of resectable metastatic colorectal cancer has rare surgical value.
    Fu J; Wu L; Jiang M; Tan Y; Li D; Chen F; Jiang T; Du J
    J Surg Oncol; 2016 Dec; 114(8):1004-1008. PubMed ID: 27891617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: III. Expressions of EMA, CEA, CA19-9, CDX-2, p53, Ki-67 antigen, TTF-1, vimentin, and p63 in normal mucosa and in 42 cases.
    Terada T
    Int J Clin Exp Pathol; 2013; 6(4):630-8. PubMed ID: 23573309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential therapeutic targets discovery by transcriptome analysis of an in vitro human gastric signet ring carcinoma model.
    Yamaguchi K; Yoshihiro T; Ariyama H; Ito M; Nakano M; Semba Y; Nogami J; Tsuchihashi K; Yamauchi T; Ueno S; Isobe T; Shindo K; Moriyama T; Ohuchida K; Nakamura M; Nagao Y; Ikeda T; Hashizume M; Konomi H; Torisu T; Kitazono T; Kanayama T; Tomita H; Oda Y; Kusaba H; Maeda T; Akashi K; Baba E
    Gastric Cancer; 2022 Sep; 25(5):862-878. PubMed ID: 35661943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic alteration of the E-cadherin/catenin complex during cell differentiation and invasion of undifferentiated-type gastric carcinomas.
    Nakamura E; Sugihara H; Bamba M; Hattori T
    J Pathol; 2005 Feb; 205(3):349-58. PubMed ID: 15682444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment and characterization of novel gastric signet-ring cell and non signet-ring cell poorly differentiated adenocarcinoma cell lines with low and high malignant potential.
    Murakami H; Nakanishi H; Tanaka H; Ito S; Misawa K; Ito Y; Ikehara Y; Kondo E; Kodera Y
    Gastric Cancer; 2013 Jan; 16(1):74-83. PubMed ID: 22450770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiating breast carcinoma with signet ring features from gastrointestinal signet ring carcinoma: assessment of immunohistochemical markers.
    Hui Y; Wang Y; Nam G; Fanion J; Sturtevant A; Lombardo KA; Resnick MB
    Hum Pathol; 2018 Jul; 77():11-19. PubMed ID: 29317235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcomatoid renal cell carcinoma is an example of epithelial--mesenchymal transition.
    Conant JL; Peng Z; Evans MF; Naud S; Cooper K
    J Clin Pathol; 2011 Dec; 64(12):1088-92. PubMed ID: 22003062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary signet-ring cell carcinoma of the lung: histochemical and immunohistochemical characterization.
    Hayashi H; Kitamura H; Nakatani Y; Inayama Y; Ito T; Kitamura H
    Hum Pathol; 1999 Apr; 30(4):378-83. PubMed ID: 10208457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial-Mesenchymal Expression Phenotype of Primary Melanoma and Matched Metastases and Relationship with Overall Survival.
    Yan S; Holderness BM; Li Z; Seidel GD; Gui J; Fisher JL; Ernstoff MS
    Anticancer Res; 2016 Dec; 36(12):6449-6456. PubMed ID: 27919967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary lung carcinoma with signet-ring cell carcinoma components: clinicopathological analysis of 39 cases.
    Tsuta K; Ishii G; Yoh K; Nitadori J; Hasebe T; Nishiwaki Y; Endoh Y; Kodama T; Nagai K; Ochiai A
    Am J Surg Pathol; 2004 Jul; 28(7):868-74. PubMed ID: 15223955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonneoplastic signet-ring cell change in gastrointestinal and biliary tracts: a pitfall for overdiagnosis.
    Dhingra S; Wang H
    Ann Diagn Pathol; 2011 Dec; 15(6):490-6. PubMed ID: 22082777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.